In contrast, studies involving other NSCLC cell lines (such as A549, SK-MES-1 and SPC-A1) indicate a tumor-suppressive role for PCAT19 (Tang et al., 2021; Wang B. et al., 2022). This evidence concerns the gene PCAT19 and neoplasm.